Tadalafil: Une pharmacologie uniqueLECHAT, P; PINTON, P.Progrès en urologie (Paris). 2004, Vol 14, pp 18-21, issn 1166-7087, 4 p., SUP1Conference Paper

Determination of Tadalafil in Pure Powder and Tablet Dosage Form by High-Performance Liquid ChromatographyBAROT, Tushar G; PATEL, Popatbhai K.Journal of AOAC International. 2010, Vol 93, Num 2, pp 516-522, issn 1060-3271, 7 p.Article

Time course of the interaction between tadalafil and nitratesKLONER, Robert A; HUTTER, Adolph M; EMMICK, Jeffrey T et al.Journal of the American College of Cardiology. 2003, Vol 42, Num 10, pp 1855-1860, issn 0735-1097, 6 p.Article

Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivativesAHMED, Nermin S; ALI, Amal H; EL-NASHAR, Shreen M et al.European journal of medicinal chemistry. 2012, Vol 57, pp 329-343, issn 0223-5234, 15 p.Article

Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation surveyKIM, N. N.International journal of impotence research. 2003, Vol 15, pp S13-S19, issn 0955-9930, SUP5Conference Paper

Woundtable discussion: Tadalafil study groupKLONER, Robert A; BRINDIS, Ralph G; CHEITLIN, Melvin D et al.The American journal of cardiology. 2003, Vol 92, Num 9A, pp 58M-65M, issn 0002-9149Conference Paper

The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pupsBAEK, Sang-Bin; BAHN, Geonho; KIM, Chang-Ju et al.Neuroscience letters. 2011, Vol 488, Num 1, pp 26-30, issn 0304-3940, 5 p.Article

Structural elucidation of a tadalafil analogue found as an adulterant of a herbal productPENG ZOU; PEIUNG HOU; LOW, Min-Yong et al.Food additives and contaminants. 2006, Vol 23, Num 5, pp 446-451, issn 0265-203X, 6 p.Article

Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapyMCMAHON, C. G.International journal of impotence research. 2003, Vol 15, Num 5, pp 383-384, issn 0955-9930, 2 p.Article

Refinements in reconstruction of penile skin loss using intra-operative prostaglandin injections, postoperative tadalafil application and negative pressure dressingsIBLHER, N; FRITSCHE, H.-M; KATZENWADEL, A et al.Journal of plastic, reconstructive & aesthetic surgery. 2012, Vol 65, Num 10, pp 1377-1383, issn 1748-6815, 7 p.Article

Determination of tadalafil in pharmaceutical preparation by HPLC using monolithic silica columnABOUL-ENEIN, Hassan Y; ALI, Imran.Talanta (Oxford). 2005, Vol 65, Num 1, pp 276-280, issn 0039-9140, 5 p.Article

INTRACEREBRAL HEMORRHAGE ASSOCIATED WITH USE OF TADALAFIL (CIALIS)GAZZERI, Roberto; NERONI, Massimiliano; GALARZA, Marcelo et al.Neurology. 2008, Vol 70, Num 15, pp 1289-1290, issn 0028-3878, 2 p.Article

Cardiovascular safety update of Tadalafil : Retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosingKLONER, Robert A; JACKSON, Graham; HUTTER, Adolph M et al.The American journal of cardiology. 2006, Vol 97, Num 12, pp 1778-1784, issn 0002-9149, 7 p.Article

The Long-Acting Phosphodiesterase Inhibitor Tadalafil does not Influence Athletes' VO_2max, Aerobic, and Anaerobic Thresholds in NormoxiaDI LUIGI, L; BALDARI, C; GUIDETTI, L et al.International journal of sports medicine. 2008, Vol 29, Num 2, pp 110-115, issn 0172-4622, 6 p.Article

The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. CommentaryBEASLEY, Charles M; MITCHELL, Malcolm I; RUSKIN, Jeremy N et al.Journal of the American College of Cardiology. 2005, Vol 46, Num 4, pp 678-689, issn 0735-1097, 12 p.Article

Cardiovascular effects of tadalafil in patients on common antihypertensive therapiesKLONER, Robert A; MITCHELL, Malcolm; EMMICK, Jeffrey T et al.The American journal of cardiology. 2003, Vol 92, Num 9A, pp 47M-57M, issn 0002-9149Conference Paper

Tadalafil for the Treatment of Pulmonary Arterial Hypertension: A Double-Blind 52-Week Uncontrolled Extension StudyOUDIZ, Ronald J; BRUNDAGE, Bruce H; GALIE, Nazzareno et al.Journal of the American College of Cardiology. 2012, Vol 60, Num 8, pp 768-774, issn 0735-1097, 7 p.Article

Tadalafil population pharmacokinetics in patients with erectile dysfunctionTROCONIZ, Inaki F; TILLMANN, Christiane; STAAB, Alexander et al.European journal of clinical pharmacology. 2007, Vol 63, Num 6, pp 583-590, issn 0031-6970, 8 p.Article

Focus on Phosphodiesterase Inhibitors for the Treatment of Erectile Dysfunction in Older MenLEE, Mary.Clinical therapeutics. 2011, Vol 33, Num 11, pp 1590-1608, issn 0149-2918, 19 p.Article

Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cellsHAIDER, Husnain Kh; LEE, Yun-Jung; SHUJIA JIANG et al.American journal of physiology. Heart and circulatory physiology. 2010, Vol 68, Num 5, issn 0363-6135, H1395-H1404Article

Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction : Results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS)GOMERY, P; BULLOCK, A; MCGETTIGAN, J et al.International journal of impotence research. 2007, Vol 19, Num 1, pp 76-83, issn 0955-9930, 8 p.Article

Phosphodiesterase-5 inhibitor in eisenmenger syndrome : A preliminary observational studyMUKHOPADHYAY, Saibal; SHARMA, Manish; RAMAKRISHNAN, S et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 17, pp 1807-1810, issn 0009-7322, 4 p.Article

Tadalafil pharmacokinetics in healthy subjectsFORGUE, S. Thomas; PATTERSON, Beverley E; BEDDING, Alun W et al.British journal of clinical pharmacology. 2006, Vol 61, Num 3, pp 280-288, issn 0306-5251, 9 p.Article

Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunctionBRIGANTI, Alberto; SALONIA, Andrea; DEHO, Federico et al.World journal of urology (Print). 2005, Vol 23, Num 6, pp 374-384, issn 0724-4983, 11 p.Article

Efficacy and Treatment Satisfaction with on-demand Tadalafil (Cialis®) in men with erectile dysfunction. CommentarySKOUMAL, René; CHEN, Juza; KULA, Krzysztof et al.European urology. 2004, Vol 46, Num 3, pp 362-369, issn 0302-2838, 8 p.Article